All In MedTech

FDA Clearance Tracker · P160025-S005

Astron Pulsar and Pulsar-18 Stent Systems

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 22, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P160025-S005
Device name
Astron Pulsar and Pulsar-18 Stent Systems
Applicant
Biotronik AG
Applicant location
BüLach
Received
Jun 21, 2018
Decided
Aug 22, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P160025

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

Approval for updated labeling to include clinical data from the BIOFLEX-I Study.

Source documents

Other decisions for Biotronik AG

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.